Orders from 100 GBP Free delivery from 205 GBP Ready for pickup dead drop: collect in 5 min

Substances · Phenethylamine derivatives

4-FA

C9H12FN CAS 459-02-9 Analytical reference material — not for human consumption
Preferred name
4-FA
IUPAC name
1-(4-fluorophenyl)propan-2-amine
Parent CAS number (reference)
459-02-9
Molecular formula
C9H12FN
Molecular weight
153.2 g/mol
InChIKey
DGXWNDGLEOIEGT-UHFFFAOYSA-N
PubChem
CID 9986
Source
PubChem
Verified synonyms & catalog abbreviations
4-Fluoroamphetamine para-Fluoroamphetamine 4FA 4 FA

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

4-FA

Entactogen / stimulant (dose-dependent serotonin releaser) Ring-fluorinated amphetamine (para-fluoro)
Verified PubChem & CAS Identity C9H12FN · CAS 459-02-9 · CID 9986
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 153.20 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

4-FA is a monoamine releaser. At lower oral amounts the effect is mostly stimulant. PsychonautWiki notes entactogenic, MDMA-like effects once the amount is above about 100 mg, which is exactly where its common band starts (100–130 mg). The strong band is only 130–150 mg and heavy begins above 150 mg, so the entactogenic window and the toxic window are adjacent. Dutch reports summarized on PsychonautWiki (Trimbos-instituut and NVIC) describe hemorrhagic strokes, severe headache, arrhythmias, and acute cardiac failure after increased 4-FA use. A sudden severe headache with this compound is an emergency.

Biotransformation & Active Metabolites

The parent para-fluoroamphetamine is active. It is the formula isomer of 3-FA (CAS 1626-71-7), not a higher dose of 3-FA.

Temporal Pharmacokinetics

Biphasic: an entactogenic opening at common amounts, then a conventional amphetamine tail. The cardiovascular and cerebrovascular risk is part of the profile, not a rare footnote.

  1. Onset 45–75 minutes
  2. Peak Window 2.5–3.5 hours
  3. Total Window 5–8 hours
  4. Residual / Half-Life Residual stimulation 6–12 hours. The entactogenic portion is the early peak; the later hours are stimulant and are when headache must still be taken seriously.

Threshold and the start of light are both 40 mg. Light runs 40–100 mg as a stimulant. Common 100–130 mg is where the entactogenic phase appears. Strong is only 130–150 mg and heavy is everything above 150 mg. That is a steep top end. Do not redose through a delayed 45–75 minute onset.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
40 mg
Cognitive & Sensory

Stimulant wakefulness without a roll.

Somatic & Autonomic

Pulse increase and appetite loss.

Light
40–100 mg
Cognitive & Sensory

Stimulation, mood lift, and sociability that is not yet the full entactogenic phase.

Somatic & Autonomic

Dry mouth, bruxism, and rising blood pressure.

Common Reference
100–130 mg
Cognitive & Sensory

MDMA-like warmth, empathy, and music enhancement for the first part of the course, then a stimulant remainder.

Somatic & Autonomic

Tachycardia, sweating, jaw clench, dilated pupils, and vasoconstriction.

Strong
130–150 mg
Cognitive & Sensory

Intense entactogenic stimulation with more anxiety and less additional warmth than the extra milligrams suggest.

Somatic & Autonomic

Marked hypertension. A new severe headache in this band is a stroke warning, not a tension headache to sleep off.

Heavy / Toxic Zone
150 mg+
Cognitive & Sensory

Toxic agitation rather than a better roll. PsychonautWiki's heavy line starts here.

Somatic & Autonomic

Chest pain, severe headache, possible intracranial hemorrhage, arrhythmias, hyperthermia, and seizures if tramadol or another releaser is present.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.

MDMA, 4-FMA, 5-MAPB, 6-APB, and other serotonin releasers

Additive serotonin release on a compound that already becomes entactogenic above 100 mg, plus shared cardiovascular strain.

Anything taken to ignore a sudden severe headache

Trimbos-instituut and NVIC reports summarized on PsychonautWiki link 4-FA with hemorrhagic stroke. A lateralizing headache, weakness, or confusion needs emergency care.

Elevated Hazard — Avoid

Other stimulants, cocaine, and high-dose caffeine

Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.

Alcohol, opioids, and benzodiazepines

The stimulant hides sedation. When it drops, the depressant remains.

Tramadol and DXM

Seizure threshold and extra serotonin.

Caution / Receptor Attenuation

Cannabis

Often increases heart rate and paranoid thought on the offset.

SSRIs and SNRIs

Blunt the serotonergic portion of entactogen-type members while the cardiovascular load stays. They are not protection against serotonin toxicity.

Structural Isomer & Sibling Comparison

4-FA is the entactogenic para isomer. 3-FA is the meta isomer, common 30–50 mg, more purely stimulant, and dangerous if a 4-FA-sized 100 mg dose is applied to it. 4-FMA is the N-methyl analogue, common 50–100 mg. 2-FMA does not have this entactogenic phase. The useful entactogenic band of 4-FA (about 100–130 mg) sits directly under a heavy line at 150 mg.

Physicochemical Stability & Storage

Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.

Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.

Cross-Tolerance & Dependence Profile

Both stimulant tolerance and serotonergic downshift. Repeating common amounts across a weekend loses the warm phase and keeps the blood-pressure phase. Cross-tolerance with MDMA-like releasers and amphetamines. Psychological pull to redose during the stimulant tail is high. Several weeks between entactogenic uses is the spacing that matches the serotonin cost; it is not a guarantee against stroke.

Comprehensive Analytical & Toxicological Monograph

4-FA (1-(4-fluorophenyl)propan-2-amine; PAL-303; CAS 459-02-9, PubChem CID 9986) is para-fluoroamphetamine supplied as pure powder or crystals (C9H12FN, 153.20 g/mol). It is a dose-dependent monoamine releaser: stimulant at light amounts and entactogenic once the oral amount passes about 100 mg. PsychonautWiki bands are threshold 40 mg, light 40–100 mg, common 100–130 mg, strong 130–150 mg, and heavy above 150 mg, over 5–8 hours with onset at 45–75 minutes. The entactogenic window and the heavy line are close. Dutch toxicology reports cited on PsychonautWiki describe hemorrhagic stroke, severe headache, and cardiac complications. It is the formula isomer of 3-FA but not the same dose. Do not combine with MAOIs, MDMA, other releasers, or tramadol, and treat a sudden severe headache as an emergency.

Chemical Architecture & Structural Profile

4-FA (1-(4-fluorophenyl)propan-2-amine) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C9H12FN and a molar mass of 153.2 g/mol. The parent molecule is indexed under CAS registry number 459-02-9 and in the NCBI PubChem database as CID 9986 (Standard InChIKey: DGXWNDGLEOIEGT-UHFFFAOYSA-N). This molecule shares its empirical formula (C9H12FN) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (459-02-9), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 4-FA is indexed within the Substituted amphetamines structural group. Substituted phenethylamine derivative; documented reference precautions highlight hazardous interactions with MAOIs, tramadol, and lithium salts. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulants. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations

Unsafe combinations (elevated hazard)

Uncertain combinations (caution advised)